Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The completion of the Biochemistry building reached a symbolic milestone in early October, with the unification of the building’s two phases

hole in the plasterboard resulting from the breakthrough

A short ceremony marked the occasion of breaking through the temporary wall between the two phases.

Senior scientists and project leaders were present to witness a hole being knocked through a thin plasterboard wall that had protected the final phase of the construction works. They marked the two phases of the building being brought together by passing a model of the molecular structure of penicillin through the opening – much of the work to enable the antibiotic to be used on a large scale was undertaken by Oxford researchers. The hole is now being enlarged to unify the laboratory and desk-based research facilities.

The full story is available on the University of Oxford's Estates Services website

Find out more about the completion of the Biochemistry Building

Similar stories

Long COVID: vaccination could reduce symptoms, new research suggests

While evidence suggests that people who are vaccinated before they get COVID are less likely to develop long COVID than unvaccinated people, the effectiveness of vaccination on existing long COVID has been less clear.

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.